Skip to main content
SLDB
NASDAQ Life Sciences

RA Capital Management Increases Stake in Solid Biosciences with $23.7M Open Market Purchases

Analysis by Wiseek AI
Sentiment info
Positive
Importance info
8
Price
$7.8
Mkt Cap
$604.583M
52W Low
$2.41
52W High
$8.72
Market data snapshot near publication time

Summary

RA Capital Management, a significant investor, has further increased its stake in Solid Biosciences through substantial open market purchases totaling over $23.7 million, demonstrating continued confidence in the company.


Key Events

  • Significant Open Market Purchases

    RA Capital Healthcare Fund, L.P. acquired 3,155,031 shares of common stock through open market transactions from March 11 to March 17, 2026.

  • Substantial Investment

    The aggregate purchase price for these shares totaled $23,710,116.85, representing a material increase in their beneficial ownership.

  • Increased Stake

    The reporting persons now beneficially own 9,313,756 shares, representing 9.9% of the company's common stock.

  • Post-News Accumulation

    These purchases occurred after the company's recent positive clinical data announcement and participation in a $240 million private placement, indicating continued investor confidence.


Analysis

This Schedule 13D/A filing reveals that RA Capital Management, L.P. and its affiliated funds have made significant open market purchases of Solid Biosciences common stock between March 11 and March 17, 2026. These purchases, totaling over $23.7 million, represent a substantial investment. This follows RA Capital's participation in the recent $240 million private placement announced on March 6th and comes shortly after the company announced positive interim Phase 1/2 clinical data for SGT-003 on March 11th. The continued accumulation of shares by a major institutional investor, particularly after recent positive news and a capital raise, signals strong conviction in the company's future prospects and could be viewed positively by the market.

At the time of this filing, SLDB was trading at $7.80 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $604.6M. The 52-week trading range was $2.41 to $8.72. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

SLDB - Latest Insights

SLDB
Jun 10, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $6.61
Real-time Price: $7.28 info
Change: +$0.670 (+10%) info
Market Cap: $702.93M info
SLDB
Jun 02, 2026, 7:15 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $7.43
Real-time Price: $7.28 info
Change: -$0.1542 (-2%) info
Market Cap: $702.93M info
SLDB
May 12, 2026, 4:02 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $7.72
Real-time Price: $7.28 info
Change: -$0.440 (-6%) info
Market Cap: $702.93M info
SLDB
May 07, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $6.91
Real-time Price: $7.28 info
Change: +$0.370 (+5%) info
Market Cap: $702.93M info
SLDB
Apr 30, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $7.12
Real-time Price: $7.28 info
Change: +$0.160 (+2%) info
Market Cap: $702.93M info
SLDB
Apr 10, 2026, 4:10 PM EDT
Filing Type: PRE 14A
Importance Score:
8
Price at Filing: $8.02
Real-time Price: $7.28 info
Change: -$0.740 (-9%) info
Market Cap: $702.93M info
SLDB
Mar 19, 2026, 5:04 PM EDT
Filing Type: S-3
Importance Score:
7
Price at Filing: $7.12
Real-time Price: $7.28 info
Change: +$0.160 (+2%) info
Market Cap: $702.93M info
SLDB
Mar 19, 2026, 5:03 PM EDT
Filing Type: S-3
Importance Score:
7
Price at Filing: $7.12
Real-time Price: $7.28 info
Change: +$0.160 (+2%) info
Market Cap: $702.93M info
SLDB
Mar 19, 2026, 4:01 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $7.12
Real-time Price: $7.28 info
Change: +$0.160 (+2%) info
Market Cap: $702.93M info
SLDB
Mar 17, 2026, 6:50 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Price at Filing: $7.80
Real-time Price: $7.28 info
Change: -$0.520 (-7%) info
Market Cap: $702.93M info